Affinity DataKi: 1.17E+3nMAssay Description:Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]-testosteroneMore data for this Ligand-Target Pair
Affinity DataKi: 1.30E+3nMAssay Description:Binding affinity against GST-hARLBD was measured in SC-3 cell by using [3H]-testosterone as radioligandMore data for this Ligand-Target Pair
Affinity DataKi: 1.51E+3nMAssay Description:Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]-testosteroneMore data for this Ligand-Target Pair
Affinity DataKi: 2.90E+3nMAssay Description:Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]-testosteroneMore data for this Ligand-Target Pair
Affinity DataKi: 3.38E+3nMAssay Description:Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]-testosteroneMore data for this Ligand-Target Pair
Affinity DataIC50: 0.5nMAssay Description:In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1More data for this Ligand-Target Pair
Affinity DataIC50: <1nMAssay Description:Inhibitory activity (RA1) against Prostaglandin G/H synthase 1 was calculated relative to aspirinMore data for this Ligand-Target Pair
Affinity DataIC50: <1nMAssay Description:Inhibitory activity (RA2) against Prostaglandin G/H synthase 2 was calculated relative to aspirinMore data for this Ligand-Target Pair
Affinity DataIC50: <1nMAssay Description:Inhibitory activity (RA2) against Prostaglandin G/H synthase 2 was calculated relative to aspirinMore data for this Ligand-Target Pair
Affinity DataIC50: <1nMAssay Description:Inhibitory activity (RA1) against Prostaglandin G/H synthase 1 was calculated relative to aspirinMore data for this Ligand-Target Pair
Affinity DataIC50: <1nMAssay Description:Inhibitory activity (RA1) against Prostaglandin G/H synthase 1 was calculated relative to aspirinMore data for this Ligand-Target Pair
Affinity DataIC50: <1nMAssay Description:Inhibitory activity (RA2) against Prostaglandin G/H synthase 2 was calculated relative to aspirinMore data for this Ligand-Target Pair
Affinity DataIC50: 1.90nMAssay Description:In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1More data for this Ligand-Target Pair
Affinity DataIC50: 7.60nMAssay Description:Androgen antagonistic activity as inhibitory concentration against testosterone-induced SC-3 cell proliferationMore data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:Androgen antagonistic activity as inhibitory concentration against testosterone-induced SC-3 cell proliferationMore data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: <10nMAssay Description:Inhibitory activity (RA2) against Prostaglandin G/H synthase 2 was calculated relative to aspirinMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Androgen antagonistic activity as inhibitory concentration against testosterone-induced SC-3 cell proliferationMore data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 28nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1More data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 31nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 34nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 35nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 41nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 41nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 42nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 46nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 49nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 50nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 50nMAssay Description:In vitro relative binding affinity for chick intestinal vitamin D3 receptor compared to [3H]-1More data for this Ligand-Target Pair
Affinity DataIC50: 52nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 52nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair
Affinity DataIC50: 52nMAssay Description:It was introduced human URAT1 full-length cDNA into an expression vector
pcDNA5 / FRT / V5-His TOPO (registered trademark) (Invitrogen). The
result...More data for this Ligand-Target Pair